1. Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells
   Xue Pan et al, 2008, Clinical Cancer Research CrossRef
2. Proteomic analysis of cancer tissues and cells
   Yasuhiro Kuramitsu, 2021, Electrophoresis Letters CrossRef
3. Molecular predictors of gemcitabine response in pancreatic cancer
   Ioannis A Voutsadakis, 2011, World Journal of Gastrointestinal Oncology CrossRef
4. Unraveling Potential Candidate Targets Associated with Expression of p16INK4a or p16 Truncated Fragment by Comparative Proteomics Analysis
   Najmeh Fahham et al, 2022, Current Proteomics CrossRef
5. The Role of Hsp27 in Chemotherapy Resistance
   Marios Lampros et al, 2022, Biomedicines CrossRef
6. Ferroptosis: At the Crossroad of Gemcitabine Resistance and Tumorigenesis in Pancreatic Cancer
   Jianhui Yang et al, 2021, International Journal of Molecular Sciences CrossRef
7. GLRX3, a novel cancer stem cell-related secretory biomarker of pancreatic ductal adenocarcinoma
   Jung Hyun Jo et al, 2021, BMC Cancer CrossRef
8. Identification of the drug resistance related protein and possible application for the pancreatic cancer chemotherapy.
   Yasuhiro Kuramitsu et al, 2008, SEIBUTSU BUTSURI KAGAKU CrossRef
9. Endoplasmic Reticulum Stress of Gut Enterocyte and Intestinal Diseases
   Han Gao et al, 2022, Frontiers in Molecular Biosciences CrossRef
10. Glucose metabolic phenotype of pancreatic cancer
    Anthony KC Chan et al, 2016, World Journal of Gastroenterology CrossRef
11. Power of an Organic Electron Acceptor in Modulation of Intracellular Mitochondrial Reactive Oxygen Species: Inducing JNK- and Caspase-Dependent Apoptosis of Cancer Cells
    Saswat Mohapatra et al, 2021, ACS Omega CrossRef
12. Advances in Circulating Biomarkers of Pancreatic Cancer
    一 张, 2021, Advances in Clinical Medicine CrossRef